SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-24-006125
Filing Date
2024-04-29
Accepted
2024-04-29 16:30:57
Documents
19
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A agrx-20231231x10ka.htm   iXBRL 10-K/A 920265
2 EX-4.24 agrx-20231231xex4d24.htm EX-4.24 130536
3 EX-31.1 agrx-20231231xex31d1.htm EX-31.1 11320
4 EX-31.2 agrx-20231231xex31d2.htm EX-31.2 11299
5 EX-32.1 agrx-20231231xex32d1.htm EX-32.1 7910
6 EX-32.2 agrx-20231231xex32d2.htm EX-32.2 7290
  Complete submission text file 0001558370-24-006125.txt   1416013

Data Files

Seq Description Document Type Size
7 EX-101.SCH agrx-20231231.xsd EX-101.SCH 4313
8 EX-101.DEF agrx-20231231_def.xml EX-101.DEF 38920
9 EX-101.LAB agrx-20231231_lab.xml EX-101.LAB 23472
10 EX-101.PRE agrx-20231231_pre.xml EX-101.PRE 13922
23 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20231231x10ka_htm.xml XML 7489
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36464 | Film No.: 24891490
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)